Assessment of bevacizumab resistance increased by expression of BCAT1 in IDH1 wild-type glioblastoma: application of DSC perfusion MR imaging-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Assessment of bevacizumab resistance increased by expression of BCAT1 in IDH1 wild-type glioblastoma: application of DSC perfusion MR imaging

Published:2016-09-08 Issue:43 Volume:7 Page:69606-69615
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Cho Hye Rim¹²,Hong Bora¹²,Kim Hyeonjin¹,Park Chul-Kee³,Park Sung-Hye⁴,Park Sunghyouk⁵,Choi Seung Hong¹²

Affiliation:

1. Department of Radiology, Seoul National University Hospital, Seoul, Korea

2. Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul, Korea

3. Department of Neurosurgery, Seoul National University Hospital, Seoul, Korea

4. Department of Pathology, Seoul National University Hospital, Seoul, Korea

5. College of Pharmacy, Natural Product Research Institute, Seoul National University, Seoul, Korea

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BAY-069, a Novel (Trifluoromethyl)pyrimidinedione-Based BCAT1/2 Inhibitor and Chemical Probe;Journal of Medicinal Chemistry;2022-10-19

2. The mechanism of branched-chain amino acid transferases in different diseases: Research progress and future prospects;Frontiers in Oncology;2022-09-02

3. BCAT1 Activates PI3K/AKT/mTOR Pathway and Contributes to the Angiogenesis and Tumorigenicity of Gastric Cancer;Frontiers in Cell and Developmental Biology;2021-06-07

4. BCAT1 decreases the sensitivity of cancer cells to cisplatin by regulating mTOR-mediated autophagy via branched-chain amino acid metabolism;Cell Death & Disease;2021-02

5. Branched-chain amino acid aminotransferase-1 regulates self-renewal and pluripotency of mouse embryonic stem cells through Ras signaling;Stem Cell Research;2020-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3